Literature DB >> 11864903

Serious corneoscleral complications after pterygium excision with mitomycin C.

B Safianik, I Ben-Zion, H J Garzozi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11864903      PMCID： PMC1771048          DOI： 10.1136/bjo.86.3.357

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

1.  Recurrence rate and complications after beta irradiation for pterygia.

Authors:  F D MacKenzie; L W Hirst; B Kynaston; C Bain
Journal:  Ophthalmology       Date:  1991-12       Impact factor: 12.079

2.  Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium.

Authors:  S Hayasaka; S Noda; Y Yamamoto; T Setogawa
Journal:  Am J Ophthalmol       Date:  1988-12-15       Impact factor: 5.258

3.  Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium.

Authors:  J Cano-Parra; M Diaz-Llopis; M J Maldonado; E Vila; J L Menezo
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

4.  Low-dose intraoperative mitomycin C as chemoadjuvant for pterygium surgery.

Authors:  H C Cheng; S H Tseng; P L Kao; F K Chen
Journal:  Cornea       Date:  2001-01       Impact factor: 2.651

5.  Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.

Authors:  R Rachmiel; H Leiba; S Levartovsky
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

6.  The use of low-dose mitomycin C for prevention of recurrent pterygium.

Authors:  J Frucht-Pery; M Ilsar
Journal:  Ophthalmology       Date:  1994-04       Impact factor: 12.079

7.  Serious complications of topical mitomycin-C after pterygium surgery.

Authors:  R S Rubinfeld; R R Pfister; R M Stein; C S Foster; N F Martin; S Stoleru; A R Talley; M G Speaker
Journal:  Ophthalmology       Date:  1992-11       Impact factor: 12.079

8.  Mitomycin eye drops as treatment for pterygium.

Authors:  G Singh; M R Wilson; C S Foster
Journal:  Ophthalmology       Date:  1988-06       Impact factor: 12.079
  8 in total
  25 in total

1.  Resolution of Corneal Dellen After an Uneventful Pterygium Surgery with Punctal Cautery.

Authors:  Bharti Sharma; Sushil Kumar Bajoria; Abhishek Patnaik; Ravi Barbhaya
Journal:  Cureus       Date:  2020-05-23

2.  Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study.

Authors:  Arno Hueber; Salvatore Grisanti; Michael Diestelhorst
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-04-15       Impact factor: 3.117

Review 3.  Developments and current approaches in the treatment of pterygium.

Authors:  Dilek Hacıoğlu; Hidayet Erdöl
Journal:  Int Ophthalmol       Date:  2016-09-23       Impact factor: 2.031

4.  Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction.

Authors:  Yu-Feng Yao; Wen-Ya Qiu; Yong-Ming Zhang; Scheffer C G Tseng
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-12       Impact factor: 3.117

5.  Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium.

Authors:  Jun Seok Lee; Sang Won Ha; Sung Yu; Gwang Ja Lee; Young Jeung Park
Journal:  Korean J Ophthalmol       Date:  2017-12

6.  Dellen and corneal perforation after bilateral pterygium excision in a patient with no risk factors.

Authors:  Ana González Gomez; José Luis González de Gor Crooke; Antonio García-Ben; Jose Manuel García-Campos
Journal:  BMJ Case Rep       Date:  2015-11-30

Review 7.  Corneal Molecular and Cellular Biology for the Refractive Surgeon: The Critical Role of the Epithelial Basement Membrane.

Authors:  Gustavo K Marino; Marcony R Santhiago; Andre A M Torricelli; Abirami Santhanam; Steven E Wilson
Journal:  J Refract Surg       Date:  2016-02       Impact factor: 3.573

8.  Superficial keratectomy, PTK, and mitomycin C as a combined treatment option for Salzmann's nodular degeneration: a follow-up of eight eyes.

Authors:  Riad Khaireddin; Toam Katz; Rahul B Baile; Gisbert Richard; Stephan J Linke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-05       Impact factor: 3.117

9.  Anti-fibrotic effect of rosmarinic acid on inhibition of pterygium epithelial cells.

Authors:  Ya-Yu Chen; Chia-Fang Tsai; Ming-Chu Tsai; Wen-Kang Chen; Yu-Wen Hsu; Fung-Jou Lu
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

10.  Trichostatin a inhibits corneal haze in vitro and in vivo.

Authors:  Ajay Sharma; Maneesh M Mehan; Sunilima Sinha; John W Cowden; Rajiv R Mohan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-24       Impact factor: 4.799
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.